Man Group PLC : Form 8.3
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Producers Online
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
KPMG er staðfestingaraðili vegna almenns tryggingafyrirkomulags Kaldalóns hf. KPMG hefur nú framkvæmt könnun á útreikningum útgefanda á fjárhagslegum og sérstökum skilyrðum skuldabréfa undir almenna tryggingafyrirkomulaginu. Niðurstaða KPMG staðfestir að fjárhagsleg…
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS)…
Westford, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Diagnostic Imaging Market Forecast to Grow at 5.4% CAGR from 2024 to 2031 | SkyQuest Technology SkyQuest projects that the Global Diagnostic…
HONOLULU, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Territorial Bancorp Inc. (“Territorial”) today reaffirmed the commitment of its Board of Directors to the proposed merger with Hope Bancorp, Inc. (“Hope”) that…
HAUPPAUGE, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced that it…
Image 1: Coherent AO-xCAO4x series of transmitter and receiver modules. PITTSBURGH, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in optical communications and laser-based technologies,…
Westford, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Corporate Wellness Market will reach a value of USD 103.94 billion by 2031, with a CAGR of…
September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for…
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has entered into…